INTENDED USE:

This kit is used for in vitro rapid qualitative detection of novel coronavirus and influenza A+B antigens in nasopharyngeal swab samples. The product is designed to be used for population screening early phase for disease outbreaks. Testing is limited to laboratories certified.

Forin vitro diagnostic use only.


Influenza A virus is more prevalent and is the primary pathogen associated with serious epidemics. Influenza B virus causes a disease that is generally not as severe as that caused by the type A virus. Both type A and B viruses can circulate simultaneously, but usually one type is dominant during a given season. Early differential diagnosis of influenza type A or type B can allow for proper treatment with appropriate antiviral therapy while reducing the incidence of inappropriate treatment with antibiotics. Early diagnosis and treatment are of particular value in a clinical setting where accurate diagnosis can assist the healthcare professional with management of influenza patients who are at risk for complications. 


Specifications: